Prema Sukumaran, Dionetta Dionysius, W. Ngeow, C. Tan, Mohd Hussin
{"title":"全身性药物治疗和植入成功:有联系吗?第三部分:抗吸收和抗血管生成药物对种植体治疗效果的影响","authors":"Prema Sukumaran, Dionetta Dionysius, W. Ngeow, C. Tan, Mohd Hussin","doi":"10.4103/jdi.jdi_24_21","DOIUrl":null,"url":null,"abstract":"Dental implants require healthy bone for successful osseointegration. However, bone health can become compromised by aging and/or the presence of underlying medical conditions. The severity and complications associated with these medical conditions usually indicate that they require medication for successful management. Some of these medications may undoubtedly exert effects on bone through direct or indirect mechanisms and, therefore, may also affect osseointegration. These include antihypertensive drugs, oral hypoglycemic agents/insulin, hormones (corticosteroid, thyroxin, and tamoxifen), and antiresorptive agents, including bisphosphonates and anti-angiogenic agents. Part three of this paper reviews the current knowledge regarding the effects of antiresorptive agents on the outcome of implant therapy.","PeriodicalId":212982,"journal":{"name":"Journal of Dental Implants","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Systemic medications and implant success: Is there a link? Part three: The effects of antiresorptive and anti-angiogenic agents on the outcome of implant therapy\",\"authors\":\"Prema Sukumaran, Dionetta Dionysius, W. Ngeow, C. Tan, Mohd Hussin\",\"doi\":\"10.4103/jdi.jdi_24_21\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Dental implants require healthy bone for successful osseointegration. However, bone health can become compromised by aging and/or the presence of underlying medical conditions. The severity and complications associated with these medical conditions usually indicate that they require medication for successful management. Some of these medications may undoubtedly exert effects on bone through direct or indirect mechanisms and, therefore, may also affect osseointegration. These include antihypertensive drugs, oral hypoglycemic agents/insulin, hormones (corticosteroid, thyroxin, and tamoxifen), and antiresorptive agents, including bisphosphonates and anti-angiogenic agents. Part three of this paper reviews the current knowledge regarding the effects of antiresorptive agents on the outcome of implant therapy.\",\"PeriodicalId\":212982,\"journal\":{\"name\":\"Journal of Dental Implants\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Dental Implants\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/jdi.jdi_24_21\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Dental Implants","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jdi.jdi_24_21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Systemic medications and implant success: Is there a link? Part three: The effects of antiresorptive and anti-angiogenic agents on the outcome of implant therapy
Dental implants require healthy bone for successful osseointegration. However, bone health can become compromised by aging and/or the presence of underlying medical conditions. The severity and complications associated with these medical conditions usually indicate that they require medication for successful management. Some of these medications may undoubtedly exert effects on bone through direct or indirect mechanisms and, therefore, may also affect osseointegration. These include antihypertensive drugs, oral hypoglycemic agents/insulin, hormones (corticosteroid, thyroxin, and tamoxifen), and antiresorptive agents, including bisphosphonates and anti-angiogenic agents. Part three of this paper reviews the current knowledge regarding the effects of antiresorptive agents on the outcome of implant therapy.